The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Intelligent Cancer Care (ICC) Market Research Report 2024

Global Intelligent Cancer Care (ICC) Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1740171

No of Pages : 108

Ask Your Query

Synopsis
Intelligent Cancer Care (ICC) is kind of information-driven network of next generation oncology solutions that bring people, data, and technology together to manage a more intelligent approach to cancer care.

Global Intelligent Cancer Care (ICC) market is projected to reach US$ 4736.9 million in 2029, increasing from US$ 891 million in 2022, with the CAGR of 28.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Intelligent Cancer Care (ICC) market research.

Key companies engaged in the Intelligent Cancer Care (ICC) industry include Varian (Siemens), CityCancerChallenge, Canon, VieCure, Sophia Genetics, Freenome, Pfizer, IBM and Sanofi, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Intelligent Cancer Care (ICC) were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Intelligent Cancer Care (ICC) market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Intelligent Cancer Care (ICC) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Varian (Siemens)
  • CityCancerChallenge
  • Canon
  • VieCure
  • Sophia Genetics
  • Freenome
  • Pfizer
  • IBM
  • Sanofi
  • GSK
  • Roche
  • Exscientia
  • BenevolentAI
  • Bayer
  • Philips
  • GE Healthcare
  • Azra AI
  • Path AI
  • NVIDIA
  • ConcertAI
  • Digital Diagnostics
  • Median Technologies
  • BioNTech SE

Segment by Type

  • Cancer Prevention and Screening
  • AI-Assisted Diagnosis
  • Prediction of Treatment Outcome
  • Intelligent Radiation Oncology
  • Tele-Oncology

Segment by Application

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Brain Tumor
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Intelligent Cancer Care (ICC) report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intelligent Cancer Care (ICC) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Cancer Prevention and Screening
1.2.3 AI-Assisted Diagnosis
1.2.4 Prediction of Treatment Outcome
1.2.5 Intelligent Radiation Oncology
1.2.6 Tele-Oncology
1.3 Market by Application
1.3.1 Global Intelligent Cancer Care (ICC) Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Prostate Cancer
1.3.5 Colorectal Cancer
1.3.6 Brain Tumor
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intelligent Cancer Care (ICC) Market Perspective (2018-2029)
2.2 Intelligent Cancer Care (ICC) Growth Trends by Region
2.2.1 Global Intelligent Cancer Care (ICC) Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Intelligent Cancer Care (ICC) Historic Market Size by Region (2018-2023)
2.2.3 Intelligent Cancer Care (ICC) Forecasted Market Size by Region (2024-2029)
2.3 Intelligent Cancer Care (ICC) Market Dynamics
2.3.1 Intelligent Cancer Care (ICC) Industry Trends
2.3.2 Intelligent Cancer Care (ICC) Market Drivers
2.3.3 Intelligent Cancer Care (ICC) Market Challenges
2.3.4 Intelligent Cancer Care (ICC) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intelligent Cancer Care (ICC) Players by Revenue
3.1.1 Global Top Intelligent Cancer Care (ICC) Players by Revenue (2018-2023)
3.1.2 Global Intelligent Cancer Care (ICC) Revenue Market Share by Players (2018-2023)
3.2 Global Intelligent Cancer Care (ICC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intelligent Cancer Care (ICC) Revenue
3.4 Global Intelligent Cancer Care (ICC) Market Concentration Ratio
3.4.1 Global Intelligent Cancer Care (ICC) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intelligent Cancer Care (ICC) Revenue in 2022
3.5 Intelligent Cancer Care (ICC) Key Players Head office and Area Served
3.6 Key Players Intelligent Cancer Care (ICC) Product Solution and Service
3.7 Date of Enter into Intelligent Cancer Care (ICC) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intelligent Cancer Care (ICC) Breakdown Data by Type
4.1 Global Intelligent Cancer Care (ICC) Historic Market Size by Type (2018-2023)
4.2 Global Intelligent Cancer Care (ICC) Forecasted Market Size by Type (2024-2029)
5 Intelligent Cancer Care (ICC) Breakdown Data by Application
5.1 Global Intelligent Cancer Care (ICC) Historic Market Size by Application (2018-2023)
5.2 Global Intelligent Cancer Care (ICC) Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Intelligent Cancer Care (ICC) Market Size (2018-2029)
6.2 North America Intelligent Cancer Care (ICC) Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Intelligent Cancer Care (ICC) Market Size by Country (2018-2023)
6.4 North America Intelligent Cancer Care (ICC) Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intelligent Cancer Care (ICC) Market Size (2018-2029)
7.2 Europe Intelligent Cancer Care (ICC) Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Intelligent Cancer Care (ICC) Market Size by Country (2018-2023)
7.4 Europe Intelligent Cancer Care (ICC) Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intelligent Cancer Care (ICC) Market Size (2018-2029)
8.2 Asia-Pacific Intelligent Cancer Care (ICC) Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Intelligent Cancer Care (ICC) Market Size by Region (2018-2023)
8.4 Asia-Pacific Intelligent Cancer Care (ICC) Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intelligent Cancer Care (ICC) Market Size (2018-2029)
9.2 Latin America Intelligent Cancer Care (ICC) Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Intelligent Cancer Care (ICC) Market Size by Country (2018-2023)
9.4 Latin America Intelligent Cancer Care (ICC) Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intelligent Cancer Care (ICC) Market Size (2018-2029)
10.2 Middle East & Africa Intelligent Cancer Care (ICC) Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Intelligent Cancer Care (ICC) Market Size by Country (2018-2023)
10.4 Middle East & Africa Intelligent Cancer Care (ICC) Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Varian (Siemens)
11.1.1 Varian (Siemens) Company Detail
11.1.2 Varian (Siemens) Business Overview
11.1.3 Varian (Siemens) Intelligent Cancer Care (ICC) Introduction
11.1.4 Varian (Siemens) Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.1.5 Varian (Siemens) Recent Development
11.2 CityCancerChallenge
11.2.1 CityCancerChallenge Company Detail
11.2.2 CityCancerChallenge Business Overview
11.2.3 CityCancerChallenge Intelligent Cancer Care (ICC) Introduction
11.2.4 CityCancerChallenge Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.2.5 CityCancerChallenge Recent Development
11.3 Canon
11.3.1 Canon Company Detail
11.3.2 Canon Business Overview
11.3.3 Canon Intelligent Cancer Care (ICC) Introduction
11.3.4 Canon Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.3.5 Canon Recent Development
11.4 VieCure
11.4.1 VieCure Company Detail
11.4.2 VieCure Business Overview
11.4.3 VieCure Intelligent Cancer Care (ICC) Introduction
11.4.4 VieCure Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.4.5 VieCure Recent Development
11.5 Sophia Genetics
11.5.1 Sophia Genetics Company Detail
11.5.2 Sophia Genetics Business Overview
11.5.3 Sophia Genetics Intelligent Cancer Care (ICC) Introduction
11.5.4 Sophia Genetics Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.5.5 Sophia Genetics Recent Development
11.6 Freenome
11.6.1 Freenome Company Detail
11.6.2 Freenome Business Overview
11.6.3 Freenome Intelligent Cancer Care (ICC) Introduction
11.6.4 Freenome Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.6.5 Freenome Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Intelligent Cancer Care (ICC) Introduction
11.7.4 Pfizer Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.7.5 Pfizer Recent Development
11.8 IBM
11.8.1 IBM Company Detail
11.8.2 IBM Business Overview
11.8.3 IBM Intelligent Cancer Care (ICC) Introduction
11.8.4 IBM Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.8.5 IBM Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Intelligent Cancer Care (ICC) Introduction
11.9.4 Sanofi Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.9.5 Sanofi Recent Development
11.10 GSK
11.10.1 GSK Company Detail
11.10.2 GSK Business Overview
11.10.3 GSK Intelligent Cancer Care (ICC) Introduction
11.10.4 GSK Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.10.5 GSK Recent Development
11.11 Roche
11.11.1 Roche Company Detail
11.11.2 Roche Business Overview
11.11.3 Roche Intelligent Cancer Care (ICC) Introduction
11.11.4 Roche Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.11.5 Roche Recent Development
11.12 Exscientia
11.12.1 Exscientia Company Detail
11.12.2 Exscientia Business Overview
11.12.3 Exscientia Intelligent Cancer Care (ICC) Introduction
11.12.4 Exscientia Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.12.5 Exscientia Recent Development
11.13 BenevolentAI
11.13.1 BenevolentAI Company Detail
11.13.2 BenevolentAI Business Overview
11.13.3 BenevolentAI Intelligent Cancer Care (ICC) Introduction
11.13.4 BenevolentAI Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.13.5 BenevolentAI Recent Development
11.14 Bayer
11.14.1 Bayer Company Detail
11.14.2 Bayer Business Overview
11.14.3 Bayer Intelligent Cancer Care (ICC) Introduction
11.14.4 Bayer Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.14.5 Bayer Recent Development
11.15 Philips
11.15.1 Philips Company Detail
11.15.2 Philips Business Overview
11.15.3 Philips Intelligent Cancer Care (ICC) Introduction
11.15.4 Philips Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.15.5 Philips Recent Development
11.16 GE Healthcare
11.16.1 GE Healthcare Company Detail
11.16.2 GE Healthcare Business Overview
11.16.3 GE Healthcare Intelligent Cancer Care (ICC) Introduction
11.16.4 GE Healthcare Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.16.5 GE Healthcare Recent Development
11.17 Azra AI
11.17.1 Azra AI Company Detail
11.17.2 Azra AI Business Overview
11.17.3 Azra AI Intelligent Cancer Care (ICC) Introduction
11.17.4 Azra AI Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.17.5 Azra AI Recent Development
11.18 Path AI
11.18.1 Path AI Company Detail
11.18.2 Path AI Business Overview
11.18.3 Path AI Intelligent Cancer Care (ICC) Introduction
11.18.4 Path AI Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.18.5 Path AI Recent Development
11.19 NVIDIA
11.19.1 NVIDIA Company Detail
11.19.2 NVIDIA Business Overview
11.19.3 NVIDIA Intelligent Cancer Care (ICC) Introduction
11.19.4 NVIDIA Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.19.5 NVIDIA Recent Development
11.20 ConcertAI
11.20.1 ConcertAI Company Detail
11.20.2 ConcertAI Business Overview
11.20.3 ConcertAI Intelligent Cancer Care (ICC) Introduction
11.20.4 ConcertAI Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.20.5 ConcertAI Recent Development
11.21 Digital Diagnostics
11.21.1 Digital Diagnostics Company Detail
11.21.2 Digital Diagnostics Business Overview
11.21.3 Digital Diagnostics Intelligent Cancer Care (ICC) Introduction
11.21.4 Digital Diagnostics Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.21.5 Digital Diagnostics Recent Development
11.22 Median Technologies
11.22.1 Median Technologies Company Detail
11.22.2 Median Technologies Business Overview
11.22.3 Median Technologies Intelligent Cancer Care (ICC) Introduction
11.22.4 Median Technologies Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.22.5 Median Technologies Recent Development
11.23 BioNTech SE
11.23.1 BioNTech SE Company Detail
11.23.2 BioNTech SE Business Overview
11.23.3 BioNTech SE Intelligent Cancer Care (ICC) Introduction
11.23.4 BioNTech SE Revenue in Intelligent Cancer Care (ICC) Business (2018-2023)
11.23.5 BioNTech SE Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock